PAL 0.00% 29.5¢ palla pharma limited

Ann: Palla 1H2019 Results Investor Presentation, page-17

  1. 2,309 Posts.
    lightbulb Created with Sketch. 261
    PAL is and will be a serial under performer.
    Bumper profit is not seen in the near future. You liked the report, don't you?! Why the market goes down all the time since then? Debt, expenditure, market sentiment and management move this share down. Litigation, money paid to solve it, lower profits in 2019 - all this is on the management and decisions taken in the past. IMO Sue MacLeman was taken on board in order to rein some of the guys. Now we are heading to new time lows, probably mid 80s. Isn't it interesting to be investor here?!
 
watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.